Literature DB >> 779006

Co-trimoxazole and nitrofurantoin in urinary-tract infections: a controlled clinical study.

A Lövestad, G Sabel, M Stefansson, B Gästrin, R Lundström.   

Abstract

The clinical efficacies of co-trimoxazole and nitrofurantoin were compared in patients with urinary-tract infections associated with significant bacteriuria with coliform bacteria tested and found to be sensitive to both drugs. Of 27 patients treated with co-trimoxazole, 23 were cured after 10 days' treatment with 320 mg trimethoprim and 1600 mg sulphamethoxazole daily (85%). Of 18 patients treated with nitrofurantoin (200 mg/day for 10 days), 7 were cured (39%). Thus, cotrimoxazole was significantly superior (p less than 0.01) in this study. A significant (p less than 0.001) but temporary and modest rise of the serum-creatinine levels was noted after 5 days' treatment with co-trimoxazole. Such a rise was not observed in the nitrofurantoin group. Only a few minor side effects were noted in both groups.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 779006

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  2 in total

1.  A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections.

Authors:  A Lövestad; B Gästrin; R Lundström
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 2.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.